ox·y·mor·phone

(ŏk′sē-môr′fōn′)

A semisynthetic opioid drug, C₁₇H₁₉NO₄, used in its hydrochloride form for the relief of moderate to severe pain, as a preoperative medication, and as an adjunct to anesthesia.

[oxy- + morph(ine) + -one.]

American Heritage® Dictionary of the English Language, Fifth Edition. Copyright © 2016 by Houghton Mifflin Harcourt Publishing Company. Published by Houghton Mifflin Harcourt Publishing Company. All rights reserved.

Translations

oxymorphone

n oximorfona

References in periodicals archive

THE FOOD AND DRUG ADMINISTRATION has asked Endo Pharmaceuticals to voluntarily remove its opioid pain medication, reformulated Opana ER (oxymorphone hydrochloride), from the market in the United States, citing the potential for its abuse as a concern.

FDA asks drug maker to shelve opioid product

Aurolife Pharma LLC, a division of Aurobindo Pharma USA, received ANDA approval for oxymorphone hydrochloride tablets, 5 mg and 10 mg.

Stream of new generic products hits the market

Pharmaceutical company Actavis Inc (NYSE:ACT) on Thursdayreported the availability of Oxymorphone Hydrochloride Extended-release Tablets, 5 mg, 10 mg, 20 mg, 30 mg and 40 mg, in the market.

Actavis Inc unveils generic version of Opana ER for treating severe pain

* OPANA (oxymorphone hydrochloride) Extended Release Tablets CII

Short supply of opioids expected

regarding the production and sale of generic formulations of OPANA ER (oxymorphone hydrochloride) Extended-Release tablets.

Medical stock spotlight: Penwest Pharmaceuticals Inc

Actavis previously received approval for, and is currently marketing, oxymorphone hydrochloride extended-release tablets, 7.5 mg and 15 mg.

More new generics are ready to hit marketplace

The product, an Oxymorphone Hydrochloride extended-release tablet, is offered in doses of 5mg, 10mg, 20mg, 30mg and 40mg.

Actavis receives FDA approval for abbreviated new drug application of generic Opana ER

All content on this website, including dictionary, thesaurus, literature, geography, and other reference data is for informational purposes only. This information should not be considered complete, up to date, and is not intended to be used in place of a visit, consultation, or advice of a legal, medical, or any other professional.